Inactivation of the invasion inhibitory gene IIp45 by alternative splicing in gliomas.

The invasion inhibitory protein 45 (IIp45) we recently identified was underexpressed in glioblastoma multiforme, the most malignant form of glioma. The IIp45 gene is located at chromosome 1p36 where frequent deletions have been reported in various types of tumors, including gliomas, raising the possibility that IIp45 may be a classic tumor suppressor gene that can be inactivated by frequent point mutations. To test this hypothesis, we sequenced the IIp45 gene in 59 diffuse glioma samples of different grades and histologic subtypes and identified a possible point mutation or a rare polymorphism in only one sample (1.7%), suggesting that IIp45 is not a classic tumor suppressor gene such as p53. Instead, reverse transcription-PCR and subsequent sequencing results revealed a tumor-specific IIp45 spliced isoform (IIp45S) in 20 of 59 (34%) gliomas examined, particularly in glioblastoma multiformes, including native tissue samples (15 of 25; 60%) and cell lines (5 of 5; 100%). The alternative splicing event is independent of 1p36 deletion, which is not common in glioblastoma multiforme. The IIp45S transcript was not detected in any of 18 normal organs, including fetal and adult brain. We determined that the IIp45S isoform results from exclusion of IIp45 exon 7 and encodes a variant protein that carries a COOH terminus different from that of IIp45 due to a frame-shift mutation. IIp45S protein was undetectable in glioma tissues, although IIp45S mRNA was prevalent. We found that IIp45S, once translated, is rapidly degraded by an ubiquitin-proteasome mechanism. Thus, the IIp45 gene is inactivated by a tumor-specific alternative splicing that generates an aberrant and unstable IIp45 isoform in infiltrative gliomas.

[1]  I. Shmulevich,et al.  Computational and Statistical Approaches to Genomics , 2007, Springer US.

[2]  J. Jónasson,et al.  Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival , 1999, British Journal of Cancer.

[3]  H. Loiseau,et al.  p73 gene transcripts in human brain tumors: overexpression and altered splicing in ependymomas , 1999, Neuroscience Letters.

[4]  Chunlei Wu,et al.  Alternative Splicing: Genetic Complexity in Cancer , 2003 .

[5]  A. Nakagawara,et al.  Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. , 1998, Cancer Research.

[6]  G. Fuller,et al.  Genomic and Molecular Neuro-Oncology , 2003 .

[7]  J. Bergthórsson,et al.  High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. , 2002, European journal of cancer.

[8]  S. Thomson,et al.  RT-PCR splicing analysis of the NF1 open reading frame , 2002, Human Genetics.

[9]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[10]  E. Goode,et al.  Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36. , 1999, American journal of human genetics.

[11]  M. Tschan,et al.  Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours , 2000, International journal of cancer.

[12]  K. Wakasa,et al.  Frequent Loss of Heterozygosity at 1p36.3 and p73 Abnormality in Parathyroid Adenomas , 2001, Modern Pathology.

[13]  G. Fuller,et al.  Fibroblast growth factor receptor-1 alpha-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. , 2000, Cancer research.

[14]  L. Zardi,et al.  Transformed human cells release different fibronectin variants than do normal cells , 1986, The Journal of cell biology.

[15]  N. L. Thangue,et al.  Promoter specificity and stability control of the p53-related protein p73 , 1999, Oncogene.

[16]  G. Fuller,et al.  IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Fuller,et al.  Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. , 2003, Cancer research.

[18]  C. Dani,et al.  Extreme instability of myc mRNA in normal and transformed human cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Nakagawara,et al.  Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells. , 1999, Cancer research.

[20]  H. Saya,et al.  Germline p53 gene mutations in subsets of glioma patients. , 1994, Journal of the National Cancer Institute.

[21]  S. Vicent,et al.  αCP-4, Encoded by a Putative Tumor Suppressor Gene at 3p21, But Not Its Alternative Splice Variant αCP-4a, Is Underexpressed in Lung Cancer , 2004, Cancer Research.

[22]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Bruner,et al.  Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Tsui,et al.  SHP-1 variant proteins are absent in motheaten mice despite presence of splice variant transcripts with open reading frames. , 1999, Molecular immunology.

[25]  K. Shimotohno,et al.  Transcriptional activities of p73 splicing variants are regulated by inter-variant association. , 2001, The Biochemical journal.

[26]  M. Berger,et al.  Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. , 1996, Cancer research.

[27]  B. Scheithauer,et al.  Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype , 1999, Oncogene.

[28]  W. Vogel,et al.  Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2. , 2002, Cancer research.

[29]  Gudrun Schleiermacher,et al.  Gene expression profiling of 1p35–36 genes in neuroblastoma , 2004, Oncogene.

[30]  W. Yung,et al.  Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. , 1999, Cancer research.

[31]  W. V. D. Van de Ven,et al.  Calcitonin gene related peptide coding sequence is conserved in the human genome and is expressed in medullary thyroid carcinoma. , 1984, The Journal of clinical endocrinology and metabolism.

[32]  O. Kallioniemi,et al.  Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. , 2000, Cancer research.